Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human FCGR2C Stable Cell Line

    [CAT#: S01YF-1023-PY160]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Fc Receptor Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    Fc Receptor
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1
    Target Classification
    Fc Receptor Cell Lines
    Target Research Area
    Immunology Research
    Related Diseases
    Immune Thrombocytopenia
    Gene ID
    Human:9103
    UniProt ID
    Human:P31995

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The applications of FCGR2C include its potential use as a biomarker for differential diagnosis of pulmonary sarcoidosis and tuberculosis, as well as for predicting the outcome of autoimmune neutropenia in early childhood. FCGR2C has also been identified as a potential biomarker and therapeutic target for obesity-related atrial fibrillation. Additionally, FCGR2C has been found to be associated with prognosis and immunotherapy response in sepsis patients. Furthermore, FCGR2C variants have been shown to influence the response to rituximab therapy for autoimmunity, suggesting its potential use in personalized treatment protocols.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human FCGR2C Stable Cell Line (S01YF-1023-PY160). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Peyton Garcia (Verified Customer)

    How does FCGR2C relate to sepsis outcomes? May 16 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    FCGR2C expression differs between survivors and non-survivors of sepsis, indicating its potential as an immune biomarker for prognosis. May 16 2020

    chat Jordan Brown (Verified Customer)

    Can FCGR2C polymorphisms influence HIV-1 acquisition? Dec 13 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Certain FCGR2C polymorphisms are associated with increased odds of perinatal HIV-1 acquisition, highlighting its role in HIV-specific immunity. Dec 13 2022

    Published Data

    Fig.1 High correlation is observed in the expression of FCGR2A and FCGR2C in human B cells.

    The Pearson correlation coefficient is displayed in the top-right corner, indicating the relationship between RefSeq annotated FCGR2C (x-axis) and FCGR2A (y-axis) in B cells across 462 individuals, with raw RNA-seq read counts represented in a scatterplot on a log2 scale.

    Ref: Peng, Xinxia, et al. "FCGR2C polymorphisms associated with HIV-1 vaccine protection are linked to altered gene expression of Fc-γ receptors in human B cells." PLoS One 11.3 (2016): e0152425.

    Pubmed: 27015273

    DOI: 10.1371/journal.pone.0152425

    Research Highlights

    Typiak, Marlena. et al. "Comparative Analysis of FCGR Gene Polymorphism in Pulmonary Sarcoidosis and Tuberculosis" Cells, 2023.
    The clinical outcome of sarcoidosis (SA) is very similar to tuberculosis (TB); however, they are treated differently and should not be confused. In search for their biomarkers, we have previously revealed changes in the phagocytic activity of monocytes in sarcoidosis and tuberculosis. On these monocytes we found a higher expression of receptors for the Fc fragment of immunoglobulin G (FcγR) in SA and TB patients vs. healthy controls. FcγRs are responsible for the binding of immune complexes (ICs) to initiate an (auto)immune response and for ICs clearance. Surprisingly, our SA patients had a high blood level of ICs, despite the abundant presence of FcγRs. It pointed to FcγR disfunction, presumably caused by the polymorphism of their (FCGR) genes. Therefore, we present here an analysis of the occurrence of FCGR2A, FCGR2B, FCGR2C, FCGR3A and FCGR3B variants in Caucasian SA and TB patients, and healthy individuals with the use of polymerase chain reaction (PCR) and real-time PCR. The presented data point to a possibility of supporting the differential diagnosis of SA and TB by analyzing FCGR2C, FCGR3A and FCGR3B polymorphism, while for severe stages of SA also by studying FCGR2A variants. Additionally, the genotyping of FCGR2A and FCGR3B might serve as a marker of SA progression.
    Typiak, Marlena. et al. "Comparative Analysis of FCGR Gene Polymorphism in Pulmonary Sarcoidosis and Tuberculosis" Cells, 2023.
    Pubmed: 37174624   DOI: 10.3390/cells12091221

    Kløve-Mogensen, Kirstine. et al. "Genetic variations in low-to-medium-affinity Fcγ receptors and autoimmune neutropenia in early childhood in a Danish cohort" International journal of immunogenetics, 2023.
    Autoimmune neutropenia (AIN) during early childhood results from autoantibodies targeting neutrophil membrane antigens and represents a common cause of childhood neutropenia. This study delves into genetic variations within the FCGR locus and FCGR3B copy number variations. Among 130 AIN patients, 64 with anti-HNA-1a antibodies and 66 with broad-reacting anti-FcγRIIIb antibodies, genotyping via multiplex ligation probe assay and real-time q-PCR compared them with healthy controls. The research reveals associations specific to antibody types, notably in the anti-HNA-1a-positive group and the HNA-1 genotype. The presence of FCGR3B copy, HNA genotypes, FCGR2A 166H, FCGR2B 232I, and FCGR2B 2B.4 copies increased AIN risk, while HNA-1bb, FCGR2A 166R, FCGR2B 232T, and one FCGR2B promoter 2B.4 copy decreased risk. These findings underscore a robust FCGR locus-AIN association in the Danish cohort and suggest potential disease heterogeneity.
    Kløve-Mogensen, Kirstine. et al. "Genetic variations in low-to-medium-affinity Fcγ receptors and autoimmune neutropenia in early childhood in a Danish cohort" International journal of immunogenetics, 2023.
    Pubmed: 36754570   DOI: 10.1111/iji.12614

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare